16th March 2025
MEDIA STATEMENT
FOR IMMEDIATE RELEASE
Endometriosis Australia is committed to improving the lives of those affected by endometriosis and is proud to see tangible progress in addressing the needs of the endometriosis community. The Albanese government’s announcement of additional listings on the Pharmaceutical Benefits Scheme (PBS) marks a significant milestone to ensure those impacted by endometriosis have access to the care and treatment they deserve.
This is a major step forward in providing much-needed financial relief for Australians living with endometriosis, as well as those undergoing fertility treatments and using contraceptive methods.
This announcement comes at a crucial time during March, which is globally recognised as Endometriosis Awareness Month. This month is dedicated to raising awareness, advocating for research, and supporting the community affected by this condition. With nearly 1 million Australians living with endometriosis – the announcement brings a glimmer of hope for the community.
Endometriosis is a painful and often debilitating condition that currently has no cure. For those suffering from moderate to severe pain, access to affordable treatment options is critical. The inclusion of Ryeqo on the PBS, which will be available from May 1, offers a treatment option at a significantly reduced cost, from $2700 per year to between $92 and $380. This change will provide financial relief, especially those who have struggled to afford treatment in the past.
Endometriosis Australia’s medical director Anusch Yazdani said the listing of Ryeqo would increase its uptake among women, especially those facing financial hardship or living in rural, remote and Indigenous communities.
“One of the biggest barriers to accessing Ryeqo has been the cost,” he said. “It’s also taken orally, so it’s easier to take than some of the existing treatments on the PBS, and has a better side-effect profile.”
The government’s commitment to improving women’s healthcare is evident in these actions, which are set to save families thousands of dollars in out-of-pocket costs. This announcement also includes more affordable access to progestogen-only contraceptives like Slinda.
As Endometriosis Australia continues to raise awareness of endometriosis this month, it is important to highlight that these positive changes in the healthcare system are a significant victory for women living with the condition. We hope this marks the beginning of further improvements in care, research, and access to treatment for all those affected by endometriosis.
Endometriosis Australia is dedicated to supporting the endometriosis community and advocating for improved healthcare outcomes for those affected by this chronic condition. The Endometriosis Nurses Scholarship offers nurses in regional and remote areas the opportunity to receive specialist training in endometriosis care, helping to drive positive change. This initiative works toward a future where everyone impacted by endometriosis has access to the care and support they rightfully deserve.
-ENDS-
For media inquiries, please contact:
media@endoaustralia.org
0
0
